The expression of lncRNA TSPOAP1-AS1 showed a significant difference between clinical stage I and II clinical pancreatic cancer samples (P < 0.05) and a greater significant difference between stage III and IV clinical pancreatic cancer samples in HNSC (P < 0.001). This evidence concerns the gene TSPOAP1 and familial pancreatic carcinoma.